US Patent 11584748 Spirocyclic compounds
Patent 11584748 was granted and assigned to C4 Therapeutics on February, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 31 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2023
Golden AI
Infobox
Golden AI
Infobox
Edits on 22 Apr, 2023
Golden AI
Infobox
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115847480
Date of Patent
February 21, 2023
0Patent Application Number
170728960
Date Filed
October 16, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 25 Mar, 2023
Golden AI
Infobox
Edits on 23 Feb, 2023
Golden AI
Edits made to:
Infobox (+17 properties)
Article (+355 characters)
US Patent 11584748 Spirocyclic compounds
Article
The present invention provides compounds which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and their use for the treatment of abnormal cellular proliferation. The present invention also provides compounds that may be used as synthetic intermediates in the synthesis of bifunctional compounds used for targeted protein degradation.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115847480
Date of Patent
February 21, 2023
0Patent Application Number
170728960
Date Filed
October 16, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11584748 Spirocyclic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
